As we continue to digest the news from Zymergen and its reverberations across the Synthetic Biology ecosystem, we wanted to take a moment to reflect in writing.

Let’s start with a statement: We steadfastly believe we are in the golden age of biology. Our conviction is driven by the unparalleled…

Content is king (or so my kids tell me). We would like to be able to say that we have a grand plan in mind behind launching curated content at KdT, including our new podcast series, The World in a Grain of Sand. But really we just want to share…

Today we’re announcing the closing of our $50M Fund II for KdT Ventures. With the announcement, one important aspect is obvious: with this fresh capital, we will double down on supporting the earliest stages of a new wave of scientist-entrepreneurs fusing data, engineering, and science to solve previously intractable problems.

N.B.- As a reminder, we are a seed-stage firm so our views relate to companies at that seed stage.

Many early stage founders balance seeking commercial validation while remaining product focused. Specifically, startups must juggle the need/desire to validate the platform through partnering/licensing a (lessor) component thereof against the need/desire…

Lately, it feels like a disproportionately large number of companies we have seen at KdT deploy or manipulate microfluidic technology of various flavors (continuous flow, droplet based, digital, etc…). For a field that has its origins in inkjet printing back in the 1970s, the team has internally been asking —…

Advances in plant genetics have provided new knowledge and technologies needed to address global food security. Millions of lives rely on crop genetic improvements keeping pace with the growing global population, changing climate, and shrinking environmental resources. Twenty-six countries (21 developing and 5 industrialized countries) planted 191.7 million hectares of…

As a firm, the team at KdT has decided to publish long-form Bio’s to help the folks we work with learn more about who we are as people. Our hope is that the openness and vulnerability that comes from sharing our stories will help enable our dialogues with all our…

Remember This?

Recently, I have become fixated on completing my sentences. Though this may sound like something the parent of a second-grader may say, it is instead bred from an intense desire to provide meaningful dialogue with those we engage with at KdT. Let’s see if I can explain this.

As an…

We heard that pictures make articles more interesting…

Consistent with our other posts here, we would like to continue to give insight and transparency around our firm’s processes and thoughts. This post is meant to provide a brief overview of our investment decision process. N.B.- …

KdT Ventures

KdT is the standard for early-stage science venture investing. We help founders and their companies re-architect the world at a molecular level.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store